合并H型高血压的急性缺血性脑卒中患者重组组织型纤溶酶原激活剂静脉溶栓后血小板平均体积/血小板计数、超敏C反应蛋白/白蛋白比值的变化及对短期预后的评估价值OA
目的 探讨合并 H 型高血压的急性缺血性脑卒中(AIS)患者重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓后血小板平均体积/血小板计数(MPV/PLT)、超敏 C 反应蛋白/白蛋白(hs-CRP/Alb)比值的变化规律,并评估其对短期预后的评估价值.方法 选取2022 年1 月至2025 年6 月在我院神经内科住院治疗的 H 型高血压合并 AIS 患者90 例,根据入院时 NIHSS 评分分为轻度组(≤7 分,32 例)、中度组(8~16 分,38例)、重度组(≥17 分,20 例);根据溶栓后90 d 改良 mRS 评分分为预后良好组(0~2 分,72 例)和预后不良组(3~6 分,18 例).采集患者基线资料,检测入院时 MPV、PLT、hs-CRP、Alb 水平并计算 MPV/PLT、hs-CRP/Alb比值.比较不同病情组间指标差异,通过单因素、多因素 Logistic 回归分析明确预后影响因素,绘制 ROC 曲线评估指标对预后的预测效能.结果 随着病情严重程度增加,MPV、hs-CRP 水平及 MPV/PLT、hs-CRP/Alb 比值逐渐升高,PLT、Alb 水平逐渐降低,三组间比较差异均有统计学意义(均 P<0.001).单因素分析显示,预后不良组门-针时间(DNT)>90 min 占比、NIHSS 评分、MPV、hs-CRP、MPV/PLT 及 hs-CRP/Alb 比值均明显高于预后良好组,PLT、Alb 水平明显低于预后良好组,且后循环梗死比例更高(均 P<0.05).多因素 Logistic 回归分析显示,DNT>90 min(OR=1.912,95%CI:1.281~2.543,P=0.027)、NIHSS 评分升高(OR=1.896,95%CI:1.325~2.698,P<0.001)、MPV/PLT 比值升高(OR=2.565,95%CI:1.543~4.265,P<0.001)、hs-CRP/Alb 比值升高(OR=3.124,95%CI:1.876~5.201,P<0.001)是预后不良的独立危险因素.ROC 曲线分析显示,MPV/PLT、hs-CRP/Alb 比值及二者联合预测预后不良的 AUC 分别为 0.845、0.809、0.907,联合预测效能高于单一指标(P<0.05).结论 H 型高血压合并溶栓后 AIS 患者 MPV/PLT、hs-CRP/Alb 比值随病情加重呈升高趋势,且二者均为 rt-PA 溶栓后短期预后不良的独立危险因素,联合检测可提高预后预测效能.
Objective To explore the changing patterns of mean platelet volume/platelet count(MPV/PLT)and high-sensitivity C-reactive protein/albumin(hs-CRP/Alb)ratios after intravenous thrombolysis with recombinant tissue plasminogen activator(rt-PA)in patients with acute ischemic stroke(AIS)complicated with H-type hypertension,and to evaluate their value in assessing short-term prognosis.Methods A total of 90 patients with H-type hypertension complicated with AIS who were hospitalized in the Department of Neurology of our hospital from January 2022 to June 2025 were selected.According to the National Institutes of NIHSS score on admission,they were divided into mild group(≤7 points,32 cases),moderate group(8-16 points,38 cases),and severe group(≥17 points,20 cases).Based on the mRS score at 90 d after thrombolysis,they were divided into good prognosis group(0-2 points,72 cases)and poor prognosis group(3-6 points,18 cases).Baseline data of patients were collected,and the levels of MPV,PLT,hs-CRP,and Alb on admission were detected to calculate MPV/PLT and hs-CRP/Alb ratios.Differences in indicators among groups with different disease severities were compared.Univariate and multivariate Logistic regression analyses were used to identify prognostic factors,and ROC curves were drawn to evaluate the predictive efficacy of the indicators for prognosis.Results With the increase of disease severity,the levels of MPV,hs-CRP,and the ratios of MPV/PLT and hs-CRP/Alb gradually increased,while PLT and Alb levels gradually decreased,with statistically significant differences among the three groups(all P<0.001).Univariate analysis showed that the door-to-needle time(DNT)>90 min,NIHSS score,MPV,hs-CRP,MPV/PLT ratio,and hs-CRP/Alb ratio in the poor prognosis group were significantly higher than those in the good prognosis group,while PLT and Alb levels were significantly lower,and the proportion of posterior circulation infarction was significantly higher(all P<0.05).Multivariate Logistic regression analysis revealed that DNT>90 min(OR=1.912,95%CI:1.281-2.543,P=0.027),increased NIHSS score(OR=1.896,95%CI:1.325-2.698,P<0.001),elevated MPV/PLT ratio(OR=2.565,95%CI:1.543-4.265,P<0.001),and increased hs-CRP/Alb ratio(OR=3.124,95%CI:1.876-5.201,P<0.001)were independent risk factors for poor prognosis.ROC curve analysis showed that the AUCs of MPV/PLT ratio,hs-CRP/Alb ratio,and their combination for predicting poor prognosis were 0.845,0.809,and 0.907,respectively,and the combined predictive efficacy was higher than that of a single indicator(P<0.05).Conclusions The MPV/PLT and hs-CRP/Alb ratio of AIS patients with H-type hypertension after thrombolysis showed an increasing trend with the aggravation of the disease and both are independent risk factors for poor short-term prognosis.Combined detection can improve the prognostic predictive efficacy.
刘成志;谢强梅;方敬献
473000 南阳市第一人民医院神经内一科473000 南阳市第一人民医院神经内一科473000 南阳市第一人民医院神经内一科
医药卫生
H型高血压急性缺血性脑卒中血小板平均体积/血小板计数比值超敏C反应蛋白/白蛋白比值重组组织型纤溶酶原激活剂预后
H-type hypertensionacute ischemic strokemean platelet volume/platelet count ratiohigh-sensitivity C-reactive protein/albumin ratiorecombinant tissue plasminogen activatorprognosis
《临床神经病学杂志》 2026 (3)
186-191,6
评论